Cargando…

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)

BACKGROUND AND AIMS: Immune semaphorins are a large family of proteins involved in the pathogenesis of inflammatory diseases through the regulation of immune homeostasis and tissue inflammation. We aim to assess the possible involvement of semaphorin3A (sema3A) and 4A (sema4A) in peripheral immune r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vadasz, Zahava, Rainis, Tova, Nakhleh, Afif, Haj, Tharwat, Bejar, Jacob, Halasz, Katty, Toubi, Elias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433250/ https://www.ncbi.nlm.nih.gov/pubmed/25978359 http://dx.doi.org/10.1371/journal.pone.0125860

Ejemplares similares

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
por: Vadasz, Zahava, et al.
Publicado: (2012)

Age-related autoimmunity
por: Vadasz, Zahava, et al.
Publicado: (2013)

The Emerging Role of IL-17 in the Immune-Pathogenesis of Chronic Spontaneous Urticaria
por: Toubi, Elias, et al.
Publicado: (2020)

Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma
por: Adi, Sabag D., et al.
Publicado: (2019)

Expression of Semaphorin 3A in Malignant and Normal Bladder Tissue: Immunohistochemistry Staining and Morphometric Evaluation
por: Bejar, Ilan, et al.
Publicado: (2021)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018)

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
por: Lobna, Matanis, et al.
Publicado: (2021)

Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?
por: Willner, Nadav, et al.
Publicado: (2018)

The Expansion of CD25(high)IL-10(high)FoxP3(high) B Regulatory Cells Is in Association with SLE Disease Activity
por: Vadasz, Zahava, et al.
Publicado: (2015)

Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases
por: Eiza, Nasren, et al.
Publicado: (2023)

Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
por: Dowdell, Alexander S., et al.
Publicado: (2021)

Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias
por: Tadmor, Tamar, et al.
Publicado: (2018)

Change in bowel habits during menstruation: are IBD patients different?
por: Lahat, Adi, et al.
Publicado: (2020)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD
por: Johnson, Amanda M., et al.
Publicado: (2021)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis
por: Nishide, Masayuki, et al.
Publicado: (2017)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
por: Rimar, D, et al.
Publicado: (2015)

Mapping Semaphorins and Netrins in the Pathogenesis of Human Thoracic Aortic Aneurysms
por: Alebrahim, Dornazsadat, et al.
Publicado: (2019)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
por: Tavassoli, Samane, et al.
Publicado: (2021)

Not All that Strictures Is IBD: Gastric Heterotopia Leading to Perforation and Small Bowel Obstruction Mimicking IBD
por: Ralbovsky, Amariel, et al.
Publicado: (2022)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD
por: Damas, Oriana M., et al.
Publicado: (2022)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Singh, Arshdeep, et al.
Publicado: (2023)

Role of Th17 Cells in the Pathogenesis of Human IBD
por: Gálvez, Julio
Publicado: (2014)

Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
por: Bates, Jennifer, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_97jk8cgui1uia93mfkj717ju2i